PTC Therapeutics Inc. (ptct 1.5 09/15/26)
13F holders, Q2 2026 (June 30)2holders +1
2new positions
1sold out
$1.55avg. 13F price*
At the end of Q2 2026, 2 institutions reported holding PTC Therapeutics Inc. (ptct 1.5 09/15/26) in their 13F filings, up 1 from Q1 2026. 2 opened new positions and 1 sold out. The largest holders were Ovata Capital Management Ltd ($21.8M) and Bank of New York Mellon Corp ($326K).
- Company
- PTC Therapeutics Inc. (ptct 1.5 09/15/26)
- CUSIP
- 69366JAD3
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $22.1M |
| Exits | 1 | $5.5M |
All 13F filers, Q1 2026 → Q2 2026: 14,280,000 shares bought and 4,156,000 shares sold, net +10,124,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Ovata Capital Management Ltd | 1.64% | New | 14,080,000 | $21.8M |
| Bank of New York Mellon Corp | 0.00% | New | 200,000 | $326K |
"% of holder's portfolio" is PTC THERAPEUTICS INC (PTCT 1.5 09/15/26)'s weight in each manager's 13F, not the share of PTC Therapeutics Inc. (ptct 1.5 09/15/26) the manager owns.